Come up with a name for your new list and we'll add to it:
Siamab Therapeutics raised a round of funding on May 06, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Siamab Therapeutics, formerly Sialix, is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of the…